Bone Biologics (BBLG) Total Current Liabilities (2016 - 2017)

Bone Biologics (BBLG) has disclosed Total Current Liabilities for 2 consecutive years, with $3.8 million as the latest value for Q3 2017.

  • On a quarterly basis, Total Current Liabilities rose 1038.07% to $3.8 million in Q3 2017 year-over-year; TTM through Sep 2017 was $3.8 million, a 1038.07% increase, with the full-year FY2016 number at $1.5 million, changed N/A from a year prior.
  • Total Current Liabilities was $3.8 million for Q3 2017 at Bone Biologics, up from $2.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $3.8 million in Q3 2017 to a low of $335622.0 in Q3 2016.